ArQule, Inc. (ARQL) financial statements (2021 and earlier)

Company profile

Business Address ONE WALL STREET
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100483139597579
Cash and cash equivalents19201514131614
Short-term investments80281625475965
Receivables6      
Prepaid expense1     
Prepaid expense and other current assets0
Other undisclosed current assets 11121 
Total current assets:106493239617680
Noncurrent Assets
Property, plant and equipment0000012
Long-term investments and receivables    42051
Long-term investments    42051
Deposits noncurrent assets    01 
Other noncurrent assets000001
Prepaid expense and other noncurrent assets1
Other undisclosed noncurrent assets    (2)(1) 
Total noncurrent assets:000122355
TOTAL ASSETS:1074932406398134
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:138967810
Accounts payable1110001
Accrued liabilities11111  
Employee-related liabilities21222  
Other undisclosed accounts payable and accrued liabilities85534810
Debt2    22
Deferred revenue and credits2 5111114
Other undisclosed current liabilities    011
Total current liabilities:1510911182227
Noncurrent Liabilities
Long-term debt and lease obligation1315     
Long-term debt, excluding current maturities1315     
Liabilities, other than long-term debt 2  51626
Deferred revenue and credits   51626
Derivative instruments and hedges, liabilities 2     
Other undisclosed noncurrent liabilities     01
Total noncurrent liabilities:1316  51627
Total liabilities:2826911233853
Temporary equity, carrying amount 9     
Stockholders' equity
Stockholders' equity attributable to parent, including:79142429416181
Common stock111111 
Additional paid in capital626547528511508505501
Accumulated other comprehensive income (loss)(0)(0)00(0)00
Accumulated deficit(548)(534)(505)(482)(468)(445)(420)
Other undisclosed stockholders' equity attributable to parent      1
Total stockholders' equity:79142429416181
TOTAL LIABILITIES AND EQUITY:1074932406398134

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Gross profit:    (1)(0) 
Operating expenses(39)(27)(28)(25)(34)(41)(48)
Other undisclosed operating income26 511111636
Operating loss:(14)(27)(23)(14)(24)(25)(11)
Nonoperating income (expense)(2)(1)00111
Investment income, nonoperating1000010
Other nonoperating income21 0100
Interest and debt expense(2)(2)  (0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(17)(29)(23)(14)(23)(25)(11)
Other undisclosed income from continuing operations before income taxes10     
Net loss available to common stockholders, diluted:(15)(29)(23)(14)(23)(25)(11)

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(15)(29)(23)(14)(23)(25)(11)
Comprehensive loss:(15)(29)(23)(14)(23)(25)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)0(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(16)(29)(23)(14)(23)(25)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: